Home » Topics » BioWorld Science

BioWorld Science
RSS

Viragen seeks to become fully integrated blood products company

Jan. 28, 1998

Vaccine delivery joint venture finalized by Endorex and Elan

Jan. 28, 1998

Japanese approval for Biora's periodontal disease product

Jan. 28, 1998

Pacific's cancer immunotherapy proves highly effective in rat metastatic mammary tumor model

Jan. 28, 1998

Phase II trials of Sibia's Parkinson's disease Rx begin

Jan. 28, 1998

Allelix: Q1 1998 highlights

Jan. 28, 1998

Antihypertensive efficacy described for Novartis' dual ACE/NEP inhibitor

Jan. 28, 1998

EUK-134 effective in animal model of stroke

Jan. 28, 1998

In vivo efficacy reported for angiotensin II blocker

Jan. 28, 1998

New test for cardiovascular disease risk assessment from Myriad Genetics

Jan. 28, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...